CRYPTYX BIOSCIENCE, INC.
Drug Discovery With Cryptic Metabolites
PRINCETON, United States · Founded 2022 · $1.3M raised
- Headquarters
- PRINCETON, New Jersey
- Employees
- 1–10
- Founded
- 2022
- Website
- cryptyxbioscience.com
- Total Funding
- $1.3M
About
Cryptyx Bioscience is a Princeton, NJ biotechnology company developing a novel small-molecule drug discovery platform based on High-Throughput Elicitor Screening (HiTES). The platform provides a rapid, efficient approach for activating silent biosynthetic gene clusters in microorganisms to unearth cryptic metabolites — potential drug leads that cannot be accessed with existing technologies, without requiring genome sequencing, cloning, or genetics. NSF SBIR Phase I and Phase II awardee.
Summary
CRYPTYX BIOSCIENCE, INC. is a Biotech company based in PRINCETON, United States, founded in 2022. It has raised $1.3M in total.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...